Academy of Medical Sciences of I.R. Iran Archives of Iranian Medicine 1029-2977 17 5 2014 05 01 Successful Treatment of Chronic Myelogenic Leukemia (CML) with Imatinib after Renal Transplantation 0 0 EN Ali Eishei Oskuei Khadijeh Makhdoomi Sara Vossoghian Mohsen Farrokhpour Journal Article Chronic Myelogenic Leukemia (CML) is a rare malignant disorder after solid organ transplantation, especially in renal transplant recipients. Imatinib Mesylate is currently approved as first line treatment of CML. Most reports on CML are from kidney recipients who received azathioprine in combination with cyclosporine and prednisolone as immunosuppressive therapy. We report a case with CML who was treated with Mycophenolate Mofetil.